2016
DOI: 10.1016/j.jcyt.2016.06.011
|View full text |Cite
|
Sign up to set email alerts
|

Cellular therapy for sickle cell disease

Abstract: Sickle cell disease (SCD) is a monogenic red cell disorder affecting over 300,000 annual births worldwide and leading to significant organ toxicity and premature mortality. While chronic therapies such as hydroxyurea have improved outcomes, more durable therapeutic and curative options are still being investigated. Newer understanding of the disease has implicated invariant NKT (iNKT) cells as a critical immune profile that potentiates SCD. Hence, targeting this cell population may offer a new approach to dise… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 66 publications
0
7
0
Order By: Relevance
“…Sickle cell anemia is one of the most common monogenic red cell disorders worldwide. It is a multi-system disorder, associated with episodes of acute illness, progressive organ damage and premature death [1,2]. Although all homozygous sickle cell disease patients have the same genetic alteration in their DNA, they experience a wide spectrum of clinical manifestations, ranging from an almost asymptomatic condition to severe illness.…”
Section: Introductionmentioning
confidence: 99%
“…Sickle cell anemia is one of the most common monogenic red cell disorders worldwide. It is a multi-system disorder, associated with episodes of acute illness, progressive organ damage and premature death [1,2]. Although all homozygous sickle cell disease patients have the same genetic alteration in their DNA, they experience a wide spectrum of clinical manifestations, ranging from an almost asymptomatic condition to severe illness.…”
Section: Introductionmentioning
confidence: 99%
“…SCD is one of the most common autosomal recessive blood hereditary diseases, affecting approximately 300,000 newborns every year (Abraham et al, 2016). Single nucleotide mutation in the Hb β-chain coding gene is responsible for the molecular mechanism of this disease occurrence (Dever et al, 2016;Kato et al, 2018).…”
Section: Sickle Cell Disease-and Hemophilia-associated Osteoarthritismentioning
confidence: 99%
“…They subsequently classified 14 viruses as belonging to the Bunyamwera group viruses and further identified five subgroups or complexes: Bunyamwera, Cache Valley, Wyeomyia, Kairi, and Guaroa ( 43 ). In 1978, this classification was updated based on the antigenic relationships of Bunyamwera group viruses established by the cross-neutralization pattern of virus-specific hyperimmune antibodies ( 44 , 45 ). From this effort emerged three subgroups that diverge largely over geographic origin: South America, Africa, and Europe/Asia (of which BATV is the only member) ( 28 ).…”
Section: Classification Genomic Characteristics and Replication In mentioning
confidence: 99%